Release Date: April 2, 2019 Expiration Date: March 31, 2021 (subject to change)
CE for this activity will not be available after this date.
Overview While elder adults may be less affected by- and more tolerant of- sleep disruption than their younger counterparts, chronic insomnia in the elderly has been associated with higher mortality rates. In this journal monograph, three sleep specialists including an NP, PA and MD, will guide the learner to understand mechanisms which drive sleep, factors which contribute to poor sleep (in various stages) and to identify appropriate therapies for treating chronic sleep disorder.
Read this activity description, including objectives and disclosures.
Complete the educational content completely:
Read the article in its entirety
Review all additional materials provided (handouts, posttest reviews, all other downloadable resources).
After completing all content, go to Steps to Receive Credit
Complete the posttest with a score of 70% or better
Complete the evaluation and submit to receive full AANP CE/Rx credit.
Understand underlying mechanisms of systems that drive and maintain sleep.
Recognize medical, psychiatric, pharmacologic and environmental factors that contribute to chronic insomnia.
Identify the most appropriate first-line chronic insomnia therapies for individual elderly patients and second-and third-line treatments along with adjunctive measures, based on clinical recommendations.
Faculty Teresa D. Valerio, DNP, MSA, APRN, FNP-BC, DBSM Sharon M. O’Brien MPAS, PA-C Daniel J. Buysse, MD Disclosure This activity was planned in accordance with AANP Accreditation Standards and Policies. Dr. Valerio and Sharon O'Brien have no relevant affiliations to disclose. Dr Buysse discloses the following affiliations: Consultant for BeHealth and Consultant and CME Content Development for CME Institute.
This educational activity may contain opinions of the speakers from their personal experience. The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.Additional Information For questions about this online CE activity, or more information concerning the AANP CE Center, contact the AANP CE Center Manager at CECenter@aanp.org.
1 Contact Hour(s) of CE, 0.5 of which may be applied towards Pharmacology
Additional CE activities of interest
(OnDemand) Depression, Dementia & Delirium in Older Adults
(OnDemand) Arthritis 2019
(OnDemand) Influenza Update and Review
(Publication ) Osteoporosis Screening and Treatment: A Collaborative Approach
(Multi-Module) Introductory Certificate of Obesity Management in Primary Care (Modules 1-7)
(Publication ) Nonalcoholic Fatty Liver Disease: Evidence-Based Management and Early Recognition of Nonalcoholic Steatohepatitis
(OnDemand) Antibiotics Infection and the Evidence: 2019 Update
(Publication ) FNP Scope of Practice Issues When Treating Mental Health Patients
(OnDemand) I Just Need a Little Something: What's So Wrong About Benzos?
(OnDemand) Advanced Hepatitis C Treatment: The NP’s Role in Eradicating the Disease in the Community
(OnDemand) Hypoglycemia: Advanced Management in the Adult Patient